Nuclear Medicine Europe (ex AIPES) represents many of the major pharmaceutical & Imaging equipment companies in the field of Nuclear Medicine in Europe. The combination of radiopharmaceuticals & state-of-the-art imaging permits noninvasive visualization of organs, function & structure within the body. Nuclear medicine is used in the diagnosis, management, treatment & prognosis of diseases across a broad range of medical specialties, such as oncology, cardiovascular & neurology to name a few, and as such is an integral part of patient care.

Nuclear medicine is unique its ability to diagnose early detection of disease and permit early treatment before the progression of disease improving the prognosis for the patient. Nuclear Medicine Europe provides a wide scope of services & partnerships on behalf of our members. We maintain close contacts with the EU commission, politicians, the European Medicines Agency, academia & the media. We also have partnerships with key EU Patient associations & other professional bodies in the healthcare field.

Working closely with the EANM & associated medical societies, our objective is to raise awareness of the role and benefit of nuclear medicine and collectively continue to further research into molecular healthcare and its benefits for the citizens of Europe.